High | 0.170 |
Low | 0.160 |
Open | 0.160 |
Volume | 4,282,400 |
Volume (B/S) | 1,998,600 / 317,700 |
Price Bid/Ask | 0.160 / 0.165 |
52w | 0.090 - 0.280 |
ROE | -21.63 |
P/E | -31.37 |
EPS | -0.53 |
DPS | |
DY | 0.00% |
NTA | 0.0245 |
P/B | 6.73 |
RPS | 2.48 |
PSR | 6.65 |
Market Cap | 221.4M |
Shares (mil) | 1,341.59 |
YoY | RYoY |
CAGR |
3Y
14.5%
TTM
19.5%
5Y
-22.5%
TTM
-24.2%
|
RSI(14) | Neutral 43.6 |
Stochastic(14) | Neutral 45.5 |
Average Volume (3M) | 32,113,700 |
Relative Volume | 0.1 |
Financial Year | Revenue ('000) | Net ('000) | EPS | DP% | Net % | Report |
---|---|---|---|---|---|---|
31 Mar, 2025 | 7,702 | -2,807 | -0.2300 | - | ||
31 Mar, 2024 | 33,045 | -6,203 | -0.5100 | - | 50.0% | View |
31 Mar, 2023 | 27,045 | -12,403 | -1.0500 | - | 36.7% | View |
31 Mar, 2022 | 22,822 | -19,606 | -2.1500 | - | 97.7% | View |
31 Mar, 2021 | 32,498 | -9,919 | -0.9000 | - | 184.9% | View |
31 Mar, 2020 | 39,333 | -3,482 | -0.4700 | - | 142.3% | View |
31 Mar, 2019 | 53,019 | 8,235 | 1.1100 | - | 413.8% | View |
31 Mar, 2018 | 72,974 | -2,624 | -0.3800 | - | 86.0% | View |
31 Mar, 2017 | 96,811 | -18,799 | -2.8200 | - | 758.9% | View |
31 Mar, 2016 | 30,979 | 2,853 | 0.1000 | - | 9.9% | View |
31 Mar, 2015 | 32,283 | 2,595 | 0.2900 | - | 59.7% | View |
31 Mar, 2014 | 32,392 | 1,625 | 0.1800 | - | 139.9% | View |
31 Mar, 2013 | 30,683 | -4,074 | -1.1500 | - | 1.7% | View |
31 Mar, 2012 | 32,269 | -4,005 | -1.1000 | - | 440.9% | View |
31 Mar, 2011 | 83,443 | 1,175 | 0.0700 | - | 50.3% | View |
31 Mar, 2010 | 22,271 | 782 | 0.2100 | - | 7.6% | View |
31 Mar, 2009 | 21,476 | 846 | 0.2500 | - | 136.2% | View |
31 Mar, 2008 | 17,493 | -2,339 | -0.7000 | - | 526.8% | View |
31 Mar, 2007 | 17,720 | 548 | 0.1700 | - | 105.6% | View |
31 Mar, 2006 | 14,678 | -9,825 | -3.5200 | - | 46.9% | View |
31 Mar, 2005 | 10,165 | -18,504 | -7.2200 | - | 713.1% | View |
31 Mar, 2004 | 31,868 | 3,018 | 1.4300 | - | View |
Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator |
---|
No dividends
Announced | EX Date | Subject | Ratio | Offer | |
---|---|---|---|---|---|
12 Feb 2020 | 25 Feb 2020 | Rights Issue | 8.0000 : 3.000 | 0.0100 | View |
Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity | |
---|---|---|---|---|---|---|---|---|
NOVAMSC-PA | 0.170 | 0.04 | 1 | 2025-03-23 | View |
Recent News
-
Trading ideas: TNB, Public Bank, Kelington, Binastra, Jati Tinggi, Eversendai, Gadang, Nova MSC, Resintech
KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.TheStar -
Nova bags health contract in Brunei
PETALING JAYA: Nova MSC Bhd, via its subsidiary, EyRIS Pte Ltd, has secured a contract worth RM7.13mil from JPMCnova Sdn Bhd for the rollout of the national diabetic retinopathy (DR) screening programme in Brunei.TheStar -
Nova MSC获713万合约 在汶莱提供糖尿病视网膜病变筛查
(吉隆坡9日讯)Nova MSC Bhd(KL:NOVAMSC)获得价值713万令吉的合约,在汶莱开展国家糖尿病视网膜病变(NDR)筛查项目。TheEdge -
Nova MSC to provide AI-driven diabetic retinopathy screening in Brunei
Nova MSC Bhd (KL:NOVAMSC), which provides software for the healthcare sector, has secured a contract to roll out the National Diabetic Retinopathy (NDR) screening programme in Brunei.TheEdge -
Nova MSC bags RM7.13mil contract for AI-driven National DR screening programme in Brunei
PETALING JAYA: Nova MSC Bhd, via its subsidiary EyRIS Pte Ltd, has secured a contract worth RM7.13mil from JPMCnova Sdn Bhd to Roll out of the National Diabetic Retinopathy (DR) Screening Program in Brunei Darussalam.TheStar
Recent Announcements
-
General Meetings: Outcome of Meeting
-
OTHERS
NOVA MSC BERHAD (NOVAMSC OR THE COMPANY) EYRIS Pte Ltd, a subsidiary of NOVAMSC, secures RM7.13 million project order in Brunei Darussalam -
Additional Listing Announcement /Subdivision of Shares
-
Quarterly rpt on consolidated results for the financial period ended 30/06/2024
-
Additional Listing Announcement /Subdivision of Shares